Speech-Language Pathologists in West New York, NJ Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Mrs. Indira Morales, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 63rd St Apt 2, West New York, NJ 07093 Phone: 201-430-4986

Ashley Danger Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6129 Jefferson St, West New York, NJ 07093 Phone: 201-355-6526

Miriam Sarco Grau Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5404 Kennedy Blvd W, 2nd Floor, West New York, NJ 07093 Phone: 551-482-6948

Bomi Kim Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 571 56th St Apt 406, West New York, NJ 07093 Phone: 847-791-1354

Keysha Dacasin, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6028 Broadway, West New York, NJ 07093 Phone: 201-736-7467

Mrs. Mimi Jung Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 62nd St, West New York, NJ 07093 Phone: 347-525-7123

News Archive

Researchers identify new gene that helps maintain chromosome number in cells

Molecular biologists at UT Southwestern Medical Center have identified a gene called NORAD that helps maintain the proper number of chromosomes in cells, and that when inactivated, causes the number of chromosomes in a cell to become unstable, a key feature of cancer cells.

Plant scientists reveal genetic mechanism that enables viral organisms to cause diseases

CSIRO plant scientists have shed light on a problem that has puzzled researchers since the first virus was discovered in 1892 - how exactly do they cause disease? In a major breakthrough that helps us better understand how viruses cause diseases in plants - and potentially in animals and humans - Dr Ming-Bo Wang and Neil Smith of CSIRO Plant Industry have revealed a genetic mechanism that enables viral organisms to infect hosts and cause diseases.

Drug and alcohol experts to take part in T2010 conference

In August 2010, researchers and experts on drugs, alcohol and medicines will take part in the T2010 conference, the tri-annual meeting of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS). This year's meeting is being hosted by the Norwegian Institute of Public Health.

Can-Fite BioPharma submits study protocol to FDA for CF102 Phase II trial for advanced liver cancer

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has submitted a study protocol to the U.S. Food and Drug Administration for its Phase II clinical trial of CF102 for the treatment of advanced liver cancer.

Women & Infants named lead center in 14-site study of cytomegalovirus

Women & Infants Hospital of Rhode Island, through its participation in the Maternal-Fetal Medicine Units Network, has been named the lead center in a 14-site, $25 million study of cytomegalovirus (CMV), the most common infection during pregnancy.

Read more Medical News

› Verified 5 days ago